FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA PUBLIC CALENDAR

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

	February 28, 2005
FDA Official and Title	Date and Site	Other FDA Participants	Non-FDA Participants	Subject
Lester M. Crawford, Acting Commissioner of Food and Drugs	2/16/05 Switzer Bldg., Washington, D.C.	Mr. Ronan, Ms. Bond, Ms. Walcoff, and Mr. Delman	BIO - Mr. Greenwood, Mr. Werner, Mr. Phillips, and Mr. Eisenberg	Food and Drug Safety
Lester M. Crawford, Acting Commissioner of Food and Drugs	2/17/05 Switzer Bldg., Rockville, MD	John Taylor; Murray Lumpkin; Dan McChesney; Kristy Moran	Steve Kpperud, Policy Directions National Renderers Assn.: Tom Cook and Dave Meeker, American Meat Industry Foundation: Jim Hodges , American Feed INdustry Assn.: Patrick Boyle, American Feed Industry Assn.: Joel Newman, American Feed Industry Assn.: Richard Sellers	Courtesy meeting to show support for existing feed regulations
Lester M. Crawford, Acting Commissioner of Food and Drugs	2/10/05 Parklawn Bldg., Rockville, MD	Norris Alderson, Ethan Hausman, Alan Rulis, Anne Crawford, Marjorie Davidson, Susan Bond, Sheila Walcoff, Peter Vardon, Amit Sachdev, Jeff Shuren, Jeffrey Weinshenker, Hamilton Brown, Camille Brewer, and Doris Tucker	Keystone Center: Brad Sperber, Senior Associate	Discussion on status of the Keystone Contract having to do with obesity
Lester M. Crawford, Acting Commissioner of Food and Drugs	2/9/05 Switzer Bldg., Washington, D.C.	William K. Hubbard, Gerald Masoudi, and Capri McClendon	McKesson Corporation: Paul Julian, Ann Berkey, and Nacy Macan McNally	Discussion regarding drug importation and product safety
Lester M. Crawford, Acting Commissioner of Food and Drugs	2/10/05 Rockville, MD	Murray Lumpkin; Robert Brackett, Stephen Sundlof, and Susan Bond	Canadian Cattlemen's Association: Dennis Laycraft, John Masswohl, Hugh Lynch-Staunton and Blank Rome LLP: Edward Farrell (Washington counsel)	Canadian & U.S. BSE feed rules
Murray M. Lumpkin, Acting Deputy Commissioner for International and Special Programs	2/8/05 Parklawn Bldg., Rockville, MD	Mark Goldberg, Lillian Gill, John Powers, Steve Gulman, Sally Selepak and Wanda Russ	Thomas Hearn, CLSI; Glen Fine, CLSI; Mary Ferrero, CLSI; Jeff Kelman; CMS, Judy Yost, CMSand Kathleen Todd, CMS	Harmonization of Susceptibility Breakpoints Between FDA and CLSI
Murray M. Lumpkin, Acting Deputy Commissioner for International and Special Programs	2/8/05 Switzer Bldg., Washington, D.C.	Sheila Walcoff, Mary Poos, Mark Kramer, Suzanne O'Shea, Jesse Goodman, Joyce Frey-Vasconcells, Daniel Schultz, Celia Witten, Michelle Chenault, and Capri McClendon	Wake Forest University School of Medicine: Dr. Richard Dean, Dr. William Applegate, Douglas Edgeton, Dr. Anthony Atala, Dr. Sally Shumaker, Dr. David Friedman, Dr. Peter Santago	Discussion of research and product development with respect to tissue engineering and various aspects of FDA regulatory oversight
Amit K. Sachdev, Deputy Commissioner for Policy	2/17/05 Washington, D.C.	NONE	Mimi Simoneaux Kneuer, Sr. Vice President, PhARMA	Meet and Greet
Amit K. Sachdev, Deputy Commissioner for Policy	2/11/05 Parklawn Bldg., Rockville, MD	John Weiner, Elizabeth Dickinson, Gary Buehler, and Beth Clarke	Marc Goshko, Teva Pharmaceuticals; Deborah Jaskot, Teva Pharm., Jay Leftkowitz, Kirkland & Ellis, LLP; and John O'Quinn, Kirkland & Ellis, LLP	Various Issues
Amit K. Sachdev, Deputy Commissioner for Policy	2/14/05 Switzer Bldg., Washington, D.C.	Beth Clarke	Marc Himmerstein and Charles Hansen, National Environmental Strategies	Various Issues
Janet Woodcock, MD Deputy Commissioner for Operations	2/24/05 Philadelphia, PA		Kristen Hunter	Clinical Trials Congress : What Elements Relate to Clinical Trails and the FDA’s Suggestions for Improving Expediting Drug Development
Dr. Stephen F. Sundloff, Director, Center for Veterinary Medicine	2/25/05 Parklawn Bldg., Rockville, MD	Dr. Merton Smith, CVM, Dr. Murray M. Lumpkin, Kimberly Crocker, OC, and Dr. Eric Flamm, OC	French Parliamentarians	GM animals and cloning animals. Guidelines for early food safety assessment

Public Calendar Archives
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff